Product Catalog

CJC-1295 + Ipamorelin StackSpecifications & Batch COA

Classic GH optimization stack. CJC-1295 extends GH pulse duration while Ipamorelin amplifies GH release.

KERUIHK-0902CJC-1295 + Ipamorelin Stack product vial
Lyophilized PowderProduct image
Combination Formulas

CJC-1295 + Ipamorelin Stack

ResearchKERUIHK-0902

Classic GH optimization stack. CJC-1295 extends GH pulse duration while Ipamorelin amplifies GH release.

Product Specifications

CAS Number
Multiple components
Catalog Purity
≥99.41% each
Form
Lyophilized Powder
Catalog Grade
Research
View batch documentation

Product Details

CJC-1295 + Ipamorelin Stack specifications

Use the product name, catalog reference and available specifications below when discussing your requirements with our team.

Product
CJC-1295 + Ipamorelin Stack
Catalog reference
KERUIHK-0902
CAS number
Multiple components
Category
Combination Formulas
Physical form
Lyophilized Powder

Latest reported batch: CJC-1295 no DAC + Ipamorelin

Batch PB-2026-CP10-012 · Nov 2, 2026

Sample specification
CJC-1295 no DAC 5.0 mg + Ipamorelin 5.0 mg / vial (10.0 mg total)
Reported appearance
White lyophilized cake
Reported molecular weight / identity
3365.8800 / 711.3998 Da
Analytical method
Dual-component RP-HPLC / ESI-Q-TOF-MS
Storage stated in this report
−20°C, dry, sealed and protected from light

Reported analytical results

Appearance
Conforms — White intact lyophilized cake; no collapse or visible foreign matterReport specification: White lyophilized cake; no visible foreign matterMethod: Visual inspection
Reconstitution
<15 s; clear and colorless; no visible or undissolved particlesReport specification: Clear solution after reconstitutionMethod: 2.0 mL SWFI; gentle swirling
pH after Reconstitution
6.82Report specification: Meets in-house specificationMethod: Potentiometric
CJC-1295 no DAC — HPLC Purity
99.28%; RT 14.85 min; maximum related impurity 0.35% at RT 16.10 minReport specification: ≥98.0%Method: MET-CP10-RPHPLC-04
Show 12 more test results
Ipamorelin — HPLC Purity
99.52%; RT 8.62 min; maximum related impurity 0.22% at RT 9.45 minReport specification: ≥98.0%Method: MET-CP10-RPHPLC-04
CJC-1295 no DAC — Assay
5.03 mg/vial (100.6% of label)Report specification: 95.0–105.0% of 5.0 mg label claimMethod: External standard / response-factor corrected RP-HPLC
Ipamorelin — Assay
4.98 mg/vial (99.6% of label)Report specification: 95.0–105.0% of 5.0 mg label claimMethod: External standard / response-factor corrected RP-HPLC
Total Assay
10.01 mg/vialReport specification: 95.0–105.0% of 10.0 mg label claimMethod: Component assay sum
Blend Uniformity
1.12% RSD (n=10)Report specification: ≤5.0% RSDMethod: Component assay
CJC-1295 no DAC — MS Identity
3365.8800 Da; −0.0136 Da / −4.04 ppmReport specification: 3365.8936 Da; |mass error| ≤25.0 ppmMethod: ESI-Q-TOF-MS
Ipamorelin — MS Identity
711.3998 Da; +0.0141 Da / +19.87 ppmReport specification: 711.3857 Da; |mass error| ≤25.0 ppmMethod: ESI-Q-TOF-MS
Water Content
1.42%Report specification: ≤3.0%Method: Karl Fischer
Endotoxin
<1.2 EU/mgReport specification: <5.0 EU/mgMethod: Gel-clot LAL
Sterility
No microbial growth after 14 days (Oct 16–30, 2026)Report specification: SterileMethod: 14-day sterility culture
Residual TFA
<0.8%Report specification: Meets approved in-house limitMethod: Validated residual-TFA method
Residual Acetonitrile
<25 ppmReport specification: Meets approved in-house limitMethod: Validated residual-solvent method
Source COA: PB-2026-CP10-012-REL20261102
Explore this category

Batch Documentation

Certificates of Analysis

Open a batch below to view its full report in our COA library, including available analytical attachments and PDF download.

PB-2026-CP10-012Report product: CJC-1295 no DAC + Ipamorelin · CJC-1295 no DAC 5.0 mg + Ipamorelin 5.0 mg / vial (10.0 mg total)Nov 2, 2026 · Reported purity: 99.28% / 99.52%View this batch COA
PB-2026-CD-0561Report product: CJC-1295 no DAC + IpamorelinOct 14, 2026 · Reported purity: 99.22% - 99.31%View this batch COA
PB-2026-CD-0561Report product: CJC-1295 no DAC + IpamorelinSep 3, 2026 · Reported purity: 99.1%–99.3%View this batch COA

Product Inquiry

Request a CJC-1295 + Ipamorelin Stack quotation

We synthesize any sequence at any scale — from milligram research quantities to multi-kilogram commercial batches. OEM, private label, and GMP manufacturing available. Response within 24 hours.

Discuss your requirements
Back to all products